NCT03208101 - A Study to Compare LBVD to Eupenta and Imovax Polio in Healthy Adults | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 3, 2017

Primary Completion Date

September 6, 2017

Study Completion Date

December 21, 2017

Conditions

DiphtheriaTetanusPertussisPoliomyelitisHepatitis BHaemophilus Influenzae Type b Infection

Interventions

BIOLOGICAL

DTP-HepB-IPV-Hib vaccine

Hexavalent vaccine (DTP-HepB-IPV-Hib vaccine: Diphtheria-Tetanus-Pertussis-Hepatitis B-Inactivated Poliovirus-Haemophilus influenzae type b vaccine)

BIOLOGICAL

DTP-HepB-Hib vaccine & IPV

Pentavalent vaccine (DTP-HepB-Hib vaccine: Diphtheria-Tetanus-Pertussis-Hepatitis B-Haemophilus influenzae type b vaccine)+ IPV(Inactivated poliovirus vaccine)

Trial Locations (1)

Unknown

Korea University Guro Hospital, Seoul